ClinicalTrials.Veeva

Menu

Hepatocellular Carcinoma Recurrence and Anesthesia

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Hepatocellular Carcinoma

Treatments

Other: Volatile anesthetics
Other: Intravenous anesthetics

Study type

Observational

Funder types

Other

Identifiers

NCT02643173
HCC recurrence

Details and patient eligibility

About

The investigators will verify the prognosis of hepatocellular carcinoma (HCC) according to the main anesthetic agents used for the general anesthesia.

Enrollment

259 patients

Sex

All

Ages

20 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing surgery due to the HCC.

Exclusion criteria

  • Patients undergoing re-operation due to the HCC.
  • Patients presenting distant metastasis.
  • Patients undergoing liver transplantation surgery.

Trial design

259 participants in 2 patient groups

Volatile
Description:
The investigators retrospectively reviewed and analyzed the electrical medical records of patients who underwent surgery for HCC under the general anesthesia using volatile anesthetics as maintenance agents.
Treatment:
Other: Volatile anesthetics
Intravenous
Description:
The investigators retrospectively reviewed and analyzed the electrical medical records of patients who underwent surgery for HCC under the general anesthesia using intravenous anesthetics as maintenance agents.
Treatment:
Other: Intravenous anesthetics

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems